Rottinghaus Scott T.

Rottinghaus Scott T. is listed in filings as Chief Medical Officer at Enanta Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Feb 13, 2026, including sale activity. Recent filings connect the profile to Enanta Pharmaceuticals Inc (ENTA). The current snapshot covers public activity from Jul 15, 2024 to Feb 13, 2026. Reported amounts are shown as $48.6K to $1.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.